title: [Helicobacter pylori and disease].
abstract: Helicobacter pylori infection is considered an important health problem due to the fact that there are reports that describe that more than 50% of the world's populations is affected by it. The infection has been associated with multiple diseases, gastric and extra-gastric, whose signs and symptoms are overlooked most of the time. Nowadays diagnostic methods have evolved in such a way that they are available for most of the population. Among the treatment schemes is the triple therapy, which is the most effective because it reaches 90% levels of microorganism eradication. For that reason we considered it of great importance doing a review of the most relevant things in literature about this bacteria and the diseases it is associated.
authors.affiliation: Médico internista y alergólogo adscrito al servicio de neumología, Facultad de Medicina y Hospital Universitario, Universidad Autónoma de Nuevo León.
authors.forename: José Eleuterio
authors.initials: JE
authors.lastname: González Morales
authors.forename: Lucía
authors.initials: L
authors.lastname: Leal Villarreal
authors.forename: Santos
authors.initials: S
authors.lastname: Guzmán López
authors.forename: Guillermo Marcelino
authors.initials: GM
authors.lastname: Guzmán Treviño
authors.forename: Norma Alejandra
authors.initials: NA
authors.lastname: González Martínez
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000907:Antibodies, Bacterial / Q000097:blood; D001327:Autoimmune Diseases / Q000209:etiology / Q000276:immunology; D001944:Breath Tests; D002277:Carcinoma / Q000209:etiology; D002318:Cardiovascular Diseases / Q000209:etiology; D002648:Child; D002675:Child, Preschool; D016207:Cytokines / Q000097:blood; D004359:Drug Therapy, Combination / Q000008:administration & dosage / Q000627:therapeutic use; D005756:Gastritis / Q000209:etiology; D016481:Helicobacter Infections / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology / Q000276:immunology; D016480:Helicobacter pylori / Q000276:immunology / Q000472:pathogenicity* / Q000502:physiology; D006801:Humans; D012871:Skin Diseases / Q000453:epidemiology / Q000209:etiology / Q000276:immunology; D013274:Stomach Neoplasms / Q000209:etiology
chemical_list: D000900:Anti-Bacterial Agents; D000897:Anti-Ulcer Agents; D000907:Antibodies, Bacterial; D016207:Cytokines